Fangsheng Pharmaceutical announced that on October 22, 2026, the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration. Alamod tablets have obtained a drug approval number and can be produced. The drug specification is 25 mg, and the registered classification is a chemical class of 4. The drug approval number is Sinopharm's license number H20266320. It is valid until October 19, 2031. As of the announcement date, the drug project had invested a total of 8.3965 million yuan. According to data from the Mi Intranet, sales of Alamod films in 2025 exceeded 2 billion yuan, an increase of 27.09% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.